Related Experiment Video
Updated: Aug 9, 2025
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
42.9K
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021
Andrew Ford1, Angela Hwang2, Annie X Mo1
1Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA.
Vaccine
|February 21, 2023
Summary
Global vaccine research shows progress in immunization and COVID-19 vaccine development. Future efforts will focus on improving vaccine delivery, equitable access, and preparedness for future pandemics.
Area of Science:
- Vaccinology
- Infectious Disease Research
- Global Health
Background:
- The 2021 Global Vaccine and Immunization Research Forum convened to discuss advances in vaccine R&D.
- Lessons learned from COVID-19 vaccine programs were critically reviewed.
- Future opportunities for vaccine development in the current decade were explored.
Purpose of the Study:
- To highlight progress in vaccine and immunization research and development.
- To review lessons learned from COVID-19 vaccine programs.
- To identify future opportunities and challenges in vaccinology.
Main Methods:
- Forum discussions and presentations.
- Critical review of COVID-19 vaccine programs.
- Analysis of ongoing vaccine trials and pilot implementations.
Main Results:
- Decades of research investment enabled a rapid COVID-19 vaccine response.
- Unprecedented global coordination was crucial for COVID-19 vaccine creation and delivery.
- Progress was noted in tuberculosis, malaria, human papillomavirus, and poliomyelitis vaccines.
- HIV vaccine trials were halted due to lack of efficacy.
- Improvements in vaccine deliverability and equitable access are needed.
Conclusions:
- Advances in vaccine technology and global collaboration are key.
- Addressing endemic diseases and pandemic preparedness are interconnected.
- The COVID-19 response should accelerate vaccine availability for other diseases and enhance future pandemic preparedness.
Related Concept Videos
01:51Vaccinations
45.1K
Overview
45.1K
01:29Microorganisms in Medicine and Therapeutics
106
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
106
01:22Development of Immunocompetence
403
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
403
01:29Immune Response Against Viral Pathogens
861
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
861
01:30Cancer Vaccines
469
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
469
01:28International Nursing Organizations II
1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K